Loading clinical trials...
Loading clinical trials...
To improve the treatment outcome in patients with tuberculosis and integrate the pharmacogenetics into clinical practice, the information of NAT2 genotyping was used in re-challenge protocol for isoni...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Taiwan University Hospital
NCT04635111 · Hepatotoxicity, Tenosynovial Giant Cell Tumor
NCT00137059 · Hepatotoxicity
NCT00768716 · Pain, Fever, and more
National Taiwan University Hospital
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions